DexCom Shares Outstanding 2010-2024 | DXCM
DexCom shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- DexCom shares outstanding for the quarter ending September 30, 2024 were 0.410B, a 3.89% decline year-over-year.
- DexCom 2023 shares outstanding were 0.426B, a 0.47% decline from 2022.
- DexCom 2022 shares outstanding were 0.428B, a 0.3% decline from 2021.
- DexCom 2021 shares outstanding were 0.429B, a 2% increase from 2020.
| DexCom Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 426 |
| 2022 | 428 |
| 2021 | 429 |
| 2020 | 420 |
| 2019 | 369 |
| 2018 | 353 |
| 2017 | 345 |
| 2016 | 334 |
| 2015 | 319 |
| 2014 | 301 |
| 2013 | 284 |
| 2012 | 275 |
| 2011 | 262 |
| 2010 | 228 |
| 2009 | 177 |
| DexCom Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-09-30 | 410 |
| 2024-06-30 | 417 |
| 2024-03-31 | 417 |
| 2023-12-31 | 426 |
| 2023-09-30 | 427 |
| 2023-06-30 | 432 |
| 2023-03-31 | 419 |
| 2022-12-31 | 428 |
| 2022-09-30 | 426 |
| 2022-06-30 | 421 |
| 2022-03-31 | 429 |
| 2021-12-31 | 429 |
| 2021-09-30 | 430 |
| 2021-06-30 | 427 |
| 2021-03-31 | 418 |
| 2020-12-31 | 420 |
| 2020-09-30 | 398 |
| 2020-06-30 | 388 |
| 2020-03-31 | 376 |
| 2019-12-31 | 369 |
| 2019-09-30 | 370 |
| 2019-06-30 | 364 |
| 2019-03-31 | 361 |
| 2018-12-31 | 353 |
| 2018-09-30 | 361 |
| 2018-06-30 | 358 |
| 2018-03-31 | 349 |
| 2017-12-31 | 345 |
| 2017-09-30 | 347 |
| 2017-06-30 | 350 |
| 2017-03-31 | 341 |
| 2016-12-31 | 334 |
| 2016-09-30 | 336 |
| 2016-06-30 | 334 |
| 2016-03-31 | 328 |
| 2015-12-31 | 319 |
| 2015-09-30 | 322 |
| 2015-06-30 | 318 |
| 2015-03-31 | 311 |
| 2014-12-31 | 301 |
| 2014-09-30 | 304 |
| 2014-06-30 | 301 |
| 2014-03-31 | 293 |
| 2013-12-31 | 284 |
| 2013-09-30 | 286 |
| 2013-06-30 | 284 |
| 2013-03-31 | 279 |
| 2012-12-31 | 275 |
| 2012-09-30 | 276 |
| 2012-06-30 | 274 |
| 2012-03-31 | 271 |
| 2011-12-31 | 262 |
| 2011-09-30 | 270 |
| 2011-06-30 | 260 |
| 2011-03-31 | 249 |
| 2010-12-31 | 228 |
| 2010-09-30 | 233 |
| 2010-06-30 | 230 |
| 2010-03-31 | 205 |
| 2009-12-31 | 177 |
| 2009-09-30 | 184 |
| 2009-06-30 | 183 |
| 2009-03-31 | 158 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $30.978B | $3.622B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.706B | 24.73 |
| Intuitive Surgical (ISRG) | United States | $193.352B | 101.09 |
| Alcon (ALC) | Switzerland | $43.519B | 29.12 |
| Edwards Lifesciences (EW) | United States | $41.599B | 26.42 |
| IQVIA Holdings (IQV) | United States | $36.625B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $35.273B | 41.54 |
| Waters (WAT) | United States | $22.985B | 33.99 |
| STERIS (STE) | Ireland | $21.603B | 24.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.257B | 0.00 |
| Hologic (HOLX) | United States | $17.928B | 19.36 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.368B | 13.72 |
| Sysmex ADR (SSMXY) | Japan | $13.192B | 41.37 |
| Globus Medical (GMED) | United States | $11.424B | 28.93 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.192B | 44.48 |
| Teleflex (TFX) | United States | $9.024B | 14.39 |
| Glaukos (GKOS) | United States | $7.669B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.015B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.655B | 26.38 |
| Veracyte (VCYT) | United States | $3.419B | 102.61 |
| Inari Medical (NARI) | United States | $3.051B | 0.00 |
| TransMedics (TMDX) | United States | $2.857B | 90.57 |
| LivaNova (LIVN) | United Kingdom | $2.839B | 16.39 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.209B | 19.86 |
| Tandem Diabetes Care (TNDM) | United States | $2.135B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
| RxSight (RXST) | United States | $1.848B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.284B | 0.00 |
| Artivion (AORT) | United States | $1.242B | 82.28 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.901B | 15.31 |
| Paragon 28 (FNA) | United States | $0.864B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.738B | 0.00 |
| IRadimed (IRMD) | United States | $0.682B | 36.87 |
| Mesa Laboratories (MLAB) | United States | $0.660B | 15.55 |
| AxoGen (AXGN) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.561B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.503B | 29.61 |
| Tactile Systems Technology (TCMD) | United States | $0.446B | 24.14 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.241B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.160B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.140B | 15.02 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.100B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |